BlackRock Fund Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.82M Buy
176,258
+25,563
+17% +$1.23M ﹤0.01% 2586
2016
Q3
$6.88M Buy
150,695
+10,935
+8% +$439K ﹤0.01% 2674
2016
Q2
$5.58M Buy
139,760
+11,935
+9% +$437K ﹤0.01% 2730
2016
Q1
$4.45M Sell
127,825
-5,425
-4% -$199K ﹤0.01% 2803
2015
Q4
$5.73M Buy
133,250
+5,389
+4% +$270K ﹤0.01% 2766
2015
Q3
$5.57M Sell
127,861
-908
-0.7% -$49K ﹤0.01% 2740
2015
Q2
$6.64M Buy
128,769
+23,531
+22% +$1M ﹤0.01% 2750
2015
Q1
$4.12M Buy
105,238
+1,556
+2% +$61K ﹤0.01% 2934
2014
Q4
$4M Buy
103,682
+12,837
+14% +$490K ﹤0.01% 2988
2014
Q3
$3.21M Sell
90,845
-6,429
-7% -$189K ﹤0.01% 2996
2014
Q2
$2.62M Buy
97,274
+80,423
+477% +$2.09M ﹤0.01% 3092
2014
Q1
$437K Buy
16,851
+274
+2% +$6.57K ﹤0.01% 3271
2013
Q4
$359K Buy
16,577
+690
+4% +$14.1K ﹤0.01% 3275
2013
Q3
$309K Buy
15,887
+1,242
+8% +$22K ﹤0.01% 3267
2013
Q2
$228K Buy
+14,645
New +$236K ﹤0.01% 3283

Other funds holding BSTC

BlackRock Fund Advisors's BSTC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its BioSpecifics Technologies Corp. (BSTC) stake by 17% in Q4 2016, buying an estimated $1.23M and bringing the position to 176,258 shares worth $9.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

BlackRock Fund Advisors first reported a position in BSTC in Q2 2013 and has held it in 15 quarters since. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

  • BlackRock Fund Advisors held 176,258 shares of BioSpecifics Technologies Corp. worth $9.82M as of Q4 2016.
  • BlackRock Fund Advisors bought 25,563 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $1.23M.
  • BioSpecifics Technologies Corp. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2586 holding.
  • BlackRock Fund Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and has held it in 15 quarters since.
  • 96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.